Autoimmune Gastrointestinal Paralysis: Failure of Conventional Treatment without Immunomodulation
The treatment of the rare enteric nervous system (ENS) manifestations of paraneoplastic syndromes, which are most frequently associated with small cell lung cancer (SCLC), is poorly understood and described. Patients with neuroendocrine-derived tumors can develop B-cell reactivity towards the tumor...
Saved in:
Main Authors: | Craig Weinkauf, Sean McPhillips, Robert Krouse, Ira Levine |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2014-01-01
|
Series: | Case Reports in Surgery |
Online Access: | http://dx.doi.org/10.1155/2014/180654 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Role of Invariant NKT in Autoimmune Liver Disease: Can Vitamin D Act as an Immunomodulator?
by: Daniel S. Smyk, et al.
Published: (2018-01-01) -
Innovation by proxy – clusters as ecosystems facilitating open innovation
by: Marita McPhillips
Published: (2020-01-01) -
Immunomodulation in the Treatment of Refractory Catastrophic Antiphospholipid Syndrome
by: Karthik Nath, et al.
Published: (2018-01-01) -
Secretory Products of Trichinella spiralis Muscle Larvae and Immunomodulation: Implication for Autoimmune Diseases, Allergies, and Malignancies
by: Ljiljana Sofronic-Milosavljevic, et al.
Published: (2015-01-01) -
Comparison of Concomitant Mesalamine and Immunomodulator Therapy and Immunomodulator Monotherapy for Crohn’s Disease
by: Min Seob Kwak, et al.
Published: (2018-01-01)